Emmessar Biotech & Nutrition Ltd. (BSE: 524768) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹11 Cr, it ranks #5,075 by market cap among the 6,189 Indian listed companies on FinBizNet, and #63 of 63 in Pharmaceuticals. At ₹21.03 (as of 26 Oct 2026), the share price is 37.0% below its 52-week high of ₹33.38 and 14.2% above its 52-week low of ₹18.42. The share price is down 31.4% over one year and down 14.0% over three months.
| Current Price | ₹21.03 |
|---|---|
| Market Cap | ₹11 Cr |
| BSE Code | 524768 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 24.2 |
| Return on Equity | 5.51% |
| Return on Assets | 1.31% |
| 52-Week Range | ₹18.42 – ₹33.38 |
| 1-Year Price Change | -31.4% |
| 3-Month Price Change | -14.0% |
| Beta (1Y) | -0 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.ebnl.org |
Emmessar Biotech & Nutrition Limited, a healthcare company, provides healthcare and nutritional products in India and internationally. The company operates through Healthcare and Rent on Lease Land segments. It also offers CalmCream, a multi-functional skin cream; Calm Cream RESQ, a skin cream used for burns from sun, radiation, heat and chemicals; Cute-N-Comely, a cosmetic skin cream; MagiCream, a cream used for post-surgical scars; and Muscle Flex Gel, a gel used to relieve pain from aching muscles. In addition, the company offers vedaceuticals, an ayurveda disease curing medicine. Further, it provides healthcare products for dermatology, osteoporosis, anti-ageing, physical ailments, and burns, including radiation. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was incorporated in 1992 and is based in Mumbai, India.
1. Healthcare-This segment offers healthcare products. 2. Rent on Lease Land-This segment rents properties. 3. Others-0 4. Other Unallocable Expenditure (Net Off)-0
1. Rent on Leasehold Land-81.7% 2. Healthcare-18.3%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹53,132 Cr | 34.2 | 34.46% | ₹1,814 Cr | -16.1% |
| Ajanta Pharma Limited | ₹41,028 Cr | 38.9 | 25.39% | ₹1,626 Cr | +36.3% |
| Emcure Pharmaceuticals Ltd | ₹33,581 Cr | 36.3 | 19.57% | ₹2,580 Cr | +31.1% |
| Piramal Pharma Ltd | ₹25,398 Cr | -77.7 | -4.00% | ₹2,270 Cr | -1.6% |
| RUBICON RESEARCH LIMITED | ₹23,578 Cr | 93 | 19.14% | ₹534 Cr | — |
| Caplin Point Laboratories Ltdte | ₹16,891 Cr | 26.4 | 19.94% | ₹610 Cr | +10.3% |
| Pfizer Ltd. | ₹16,525 Cr | 22.9 | 17.16% | ₹653 Cr | -32.1% |
| Eris Lifesciences Ltd | ₹15,199 Cr | 24.2 | 18.07% | ₹873 Cr | -30.8% |
| Emmessar Biotech & Nutrition Ltd. | ₹11 Cr | 24.2 | 5.51% | — | -31.4% |
Listed by market capitalisation. Ratios are shown for context only.
Emmessar Biotech & Nutrition Ltd. is trading at ₹21.03, with a market capitalisation of ₹11 Cr.
Emmessar Biotech & Nutrition Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Emmessar Biotech & Nutrition Ltd. has a P/E of 24.2 and a return on equity of 5.51%.
Emmessar Biotech & Nutrition Ltd. is listed on the BSE under the scrip code 524768.
Emmessar Biotech & Nutrition Ltd.'s share price is down 31.4% over one year and down 14.0% over three months. Its 52-week range is ₹18.42 to ₹33.38.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.